These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 31130925)

  • 21. Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.
    Pfalzgraff A; Brandenburg K; Weindl G
    Front Pharmacol; 2018; 9():281. PubMed ID: 29643807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
    Tolker-Nielsen T
    APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance.
    Lopes BS; Hanafiah A; Nachimuthu R; Muthupandian S; Md Nesran ZN; Patil S
    Molecules; 2022 May; 27(9):. PubMed ID: 35566343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Resistance in
    Lupo A; Haenni M; Madec JY
    Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinatorial effects of antibiotics and enzymes against dual-species Staphylococcus aureus and Pseudomonas aeruginosa biofilms in the wound-like medium.
    Fanaei Pirlar R; Emaneini M; Beigverdi R; Banar M; B van Leeuwen W; Jabalameli F
    PLoS One; 2020; 15(6):e0235093. PubMed ID: 32584878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
    Esoda CN; Kuehn MJ
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744920
    [No Abstract]   [Full Text] [Related]  

  • 29. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens.
    Artini M; Papa R; Vrenna G; Trecca M; Paris I; D'Angelo C; Tutino ML; Parrilli E; Selan L
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
    Tiwari V; Meena K; Tiwari M
    Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of antibiotic resistance in
    Fernández-Billón M; Llambías-Cabot AE; Jordana-Lluch E; Oliver A; Macià MD
    Biofilm; 2023 Dec; 5():100129. PubMed ID: 37205903
    [No Abstract]   [Full Text] [Related]  

  • 33. Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development.
    Neff SL; Hampton TH; Koeppen K; Sarkar S; Latario CJ; Ross BD; Stanton BA
    mSystems; 2023 Dec; 8(6):e0065323. PubMed ID: 37975659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The implication of Pseudomonas aeruginosa biofilms in infections.
    Rybtke MT; Jensen PØ; Høiby N; Givskov M; Tolker-Nielsen T; Bjarnsholt T
    Inflamm Allergy Drug Targets; 2011 Apr; 10(2):141-57. PubMed ID: 21314623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents.
    Bianchera A; Buttini F; Bettini R
    Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
    Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S
    Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular Determinants of the Thickened Matrix in a Dual-Species Pseudomonas aeruginosa and Enterococcus faecalis Biofilm.
    Lee K; Lee KM; Kim D; Yoon SS
    Appl Environ Microbiol; 2017 Nov; 83(21):. PubMed ID: 28842537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.